2019
Quantitative FDG PET/CT may help risk-stratify early-stage non-small cell lung cancer patients at risk for recurrence following anatomic resection
Harmon S, Seder CW, Chen S, Traynor A, Jeraj R, Blasberg JD. Quantitative FDG PET/CT may help risk-stratify early-stage non-small cell lung cancer patients at risk for recurrence following anatomic resection. Journal Of Thoracic Disease 2019, 11: 1106-1116. PMID: 31179052, PMCID: PMC6531752, DOI: 10.21037/jtd.2019.04.46.Peer-Reviewed Original ResearchDisease-free survivalSquamous cell carcinomaNon-small cell lung cancer patientsStandardized uptake valueCell lung cancer patientsEarly-stage NSCLCLung cancer patientsDisease recurrenceAnatomic resectionOverall survivalCancer patientsF-fluorodeoxyglucose positron emission tomography/computerized tomographyEarly stage non-small cell lung cancer patientsStage I/II NSCLC patientsPositron emission tomography/computerized tomographyCox proportional hazards regressionFDG PET/CTTomography/computerized tomographyQuantitative FDG-PET/CTPathologic node statusYears of resectionPreoperative risk factorsHigh-risk patientsSignificant univariate predictorsPrimary tumor volume
2018
Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma
SEDER CW, MAHON B, HENNON M, THOMAS M, LEVEA CM, MATKOWSKYJ KA, KRISHNA M, MEDAIROS R, MACKE RA, BASU S, BLASBERG JD. Depth of Muscularis Propria Invasion Does Not Prognosticate Survival in T2 Esophageal Adenocarcinoma. Anticancer Research 2018, 38: 2195-2200. PMID: 29599339, DOI: 10.21873/anticanres.12461.Peer-Reviewed Original ResearchConceptsMuscularis propria invasionEsophageal adenocarcinomaPrognostic factorsCox proportional hazards regression analysisInferior long-term outcomesProportional hazards regression analysisPercent of patientsDisease-free survivalKaplan-Meier analysisRisk of lymphHazards regression analysisLong-term outcomesU.S. academic medical centersLong-term survivalAcademic medical centerInduction therapyMedian OSMedian ageNodal statusPerineural invasionTherapy statusSurvival differencesTumor gradeBlinded pathologistMedical Center